Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery.

MLA

Trisciuzzi, Daniela, et al. “Targeting Protein-Protein Interactions with Low Molecular Weight and Short Peptide Modulators: Insights on Disease Pathways and Starting Points for Drug Discovery.” Expert Opinion on Drug Discovery, vol. 18, no. 7, July 2023, pp. 737–52. EBSCOhost, https://doi.org/10.1080/17460441.2023.2218641.

APA

Trisciuzzi, D., Villoutreix, B. O., Siragusa, L., Baroni, M., Cruciani, G., & Nicolotti, O. (2023). Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery. Expert Opinion on Drug Discovery, 18(7), 737–752. https://doi.org/10.1080/17460441.2023.2218641

Chicago

Trisciuzzi, Daniela, Bruno O Villoutreix, Lydia Siragusa, Massimo Baroni, Gabriele Cruciani, and Orazio Nicolotti. 2023. “Targeting Protein-Protein Interactions with Low Molecular Weight and Short Peptide Modulators: Insights on Disease Pathways and Starting Points for Drug Discovery.” Expert Opinion on Drug Discovery 18 (7): 737–52. doi:10.1080/17460441.2023.2218641.